In a TCGA study with merged cohort of Low Grade Glioma (LGG) and GBM [8], PJA1, PJA2 Smad3 and altered in 9%, 4% and 14% of samples, respectively (Figure 1C). This evidence concerns the gene SMAD3 and glioma.